Publication:
Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease

dc.contributor.authorMelanie J. Hezzellen_US
dc.contributor.authorAdrian Boswooden_US
dc.contributor.authorWalasinee Moonarmarten_US
dc.contributor.authorJonathan Elliotten_US
dc.contributor.otherRoyal Veterinary College University of Londonen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-06-11T04:38:44Z
dc.date.available2018-06-11T04:38:44Z
dc.date.issued2012-03-01en_US
dc.description.abstractObjectives: To determine if echocardiographic measurements change at a greater rate in dogs with myxomatous mitral valve disease (MMVD) that die of cardiac mortality. Animals: Client-owned dogs (n = 242) with MMVD of varying severity were recruited from first opinion private practice. Only dogs which died during the study period (n = 102) were included in statistical analyses. Methods: Prospective cohort study comparing the rate of change of echocardiographic variables between dogs that experienced cardiac mortality and those that experienced non-cardiac mortality. Measurements were repeated approximately every 6 months and repeated measures linear models were constructed to estimate the rate of change of each variable over time. Results: Left ventricular (LV) end-diastolic diameter, normalized for body weight (LVEDDN) increased over time in both mortality groups. LV end-systolic diameter, normalized for body weight (LVESDN), LV end-diastolic diameter to LV free wall thickness in diastole (LVEDD/LVFWd) ratio, E wave velocity, E- to A-wave velocity ratio and left atrial to aortic root diameter ratio all increased over time in the cardiac mortality group, but did not change in the non-cardiac mortality group. MR velocity decreased over time in the cardiac mortality group but did not change in the non-cardiac mortality group. Tricuspid regurgitation jet velocity increased over time in both mortality groups. A wave velocity and fractional shortening did not change over time in either mortality group. Conclusions: Serial echocardiographic examination every 6-12 months is useful to identify dogs with progressive MMVD that are at increased risk of cardiac mortality. © 2012 Elsevier B.V. All rights reserved.en_US
dc.identifier.citationJournal of Veterinary Cardiology. Vol.14, No.1 (2012), 269-279en_US
dc.identifier.doi10.1016/j.jvc.2012.01.009en_US
dc.identifier.issn18750834en_US
dc.identifier.issn17602734en_US
dc.identifier.other2-s2.0-84858449938en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/13782
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84858449938&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectVeterinaryen_US
dc.titleSelected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve diseaseen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84858449938&origin=inwarden_US

Files

Collections